A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults

M Baay, K Bollaerts, T Verstraeten - Vaccine, 2018 - Elsevier
Introduction New adjuvants have been developed to improve the efficacy of vaccines and for
dose-sparing capacity and may overcome immuno senescence in the elderly. We reviewed …
被引用次数：21 相关文章

A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults

M Baay, K Bollaerts, T Verstraeten - Vaccine, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction New adjuvants have been developed to improve the efficacy of vaccines and for
dose-sparing capacity and may overcome immuno senescence in the elderly. We reviewed …

A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults.

M Baay, K Bollaerts, T Verstraeten - Vaccine, 2018 - europepmc.org
Methods We searched Medline for clinical trials (CTs) including new adjuvant systems
(AS01, AS02, AS03, or MF59), used in older adults, published between 01/1995 and …

A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults.

M Baay, K Bollaerts, T Verstraeten - 2018 - cabidigitallibrary.org
Introduction: New adjuvants have been developed to improve the efficacy of vaccines and
for dose-sparing capacity and may overcome immuno senescence in the elderly. We …

[引用][C] A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults

M Baay, K Bollaerts, T Verstraeten - 2018